Lisanne Blauw is currently working as an Associate at Thuja Capital, where Lisanne also holds the title of Investment Analyst. Lisanne is a Supervisory Board Observer at EsoBiotec and FundaMental Pharma. Additionally, Lisanne is the COO/Co-founder at River BioMedics. Previously, Lisanne worked as a Postdoctoral Researcher at the University of Twente and Leiden University Medical Center, focusing on genetic determinants of cholesterol and energy metabolism. Lisanne holds a Master of Science in Biomedical Engineering from Delft University of Technology, along with various other degrees and internships in the field of medicine and biomedical engineering.
January, 2023 - present
February, 2021